Hit finding is the identification of the first active compounds at a new target.
ChemDiv is capable to offer screening services for biochemical, functional and/or cellular morphological responses using its well validated screening technology platforms. This can be achieved and facilitated through access to our proprietary collection of 1.5M+ small molecule compounds or using the client’s library of compounds.
Our high-throughput screening technology platform includes all types of luminescent, fluorescent and absorption readouts, including FLIPR and multimode plate readers.
ChemDiv is offering its expertise and more than 25 years of experience in assay development, covering the major target classes. The Hit Finding can also be significantly improved through our access to high-through crystallography and comprehensive structure-based design platforms.